Prostate cancer Board decisions

The Board has granted service connection for prostate cancer, coronary artery disease, bladder cancer, and cause of death (lung cancer) due to herbicide agent exposure during the Veteran's service in the Republic of Vietnam.

The Veteran withdrew his appeals regarding the reduction in evaluation of prostate cancer and entitlement to a compensable rating for erectile dysfunction.

The Veteran's prostate cancer and diabetes are granted service connection due to herbicide exposure under the PACT Act.,Peripheral neuropathy of the upper and lower extremities, as well as chronic urticaria, are also granted service connection due to herbicide exposure.

The Board has determined that the Veteran's appeal was improperly docketed under the AMA framework and should be returned to the Legacy system for further processing.

The Veteran's entitlement to service connection for prostate cancer was improperly severed, and the Board has restored this claim effective March 31, 2016. The current law provides him with presumptive service connection due to his service on a Royal Thai Air Force Base.

The Board has remanded the Veteran's claims for prostate cancer and erectile dysfunction due to insufficient medical evidence linking these conditions to his service. The Veteran will need to undergo VA examinations to determine if his prostate cancer is etiologically related to exposure at Kelly Air Force Base, and if his erectile dysfunction is related to service or a service-connected condition.

The Veteran's prostate cancer and B-cell lymphoma are presumed to be related to his in-service exposure to Agent Orange.,The Veteran's skin disability is presumed to be related to his in-service exposure to Agent Orange.

The Veteran's prostate cancer residuals and coronary artery bypass are rated appropriately. The Board has remanded the claim for service connection of an acquired psychological condition due to insufficient evidence.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence linking his prostate condition to his military service or exposure to herbicide agents or contaminated water at Camp Lejeune. The Board also found that the Veteran did not have in-service herbicide exposure.

The Board has remanded the case due to insufficient medical opinions regarding the Veteran's prostate cancer and its relation to service. The examiner must provide a clear opinion with rationale, considering the relevant evidence including the research articles referenced in the October 2021 statement in support of claim.

The Veteran is granted a total disability rating based on individual unemployability due to service-connected disabilities from February 4, 2015 to May 2, 2017.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence to support a link between his current condition and his active military service, including exposure to non-ionizing radiation based on radar/radio waves.

The Veteran's bilateral hearing loss is rated at 40 percent since October 31, 2022. The Board also granted a total disability rating based on individual unemployability due to his service-connected disabilities.

The Veteran's claims for service connection for coronary artery disease and prostate cancer are granted. The appeal for an increased evaluation for hearing loss disability is dismissed, and the claim for service connection for erectile dysfunction is remanded.

The Veteran's cause of death, metastatic prostate cancer, is granted as service-connected due to exposure to fine particulate matter during his service in the Southwest Asia theater of operations under the PACT Act.

The Board has determined that the Veteran was exposed to environmental toxins and chemicals during service at Fallbrook Naval Weapons Station, which may be related to his prostate cancer. The VA opinion is inadequate due to its vagueness and lack of clarity regarding exposure to herbicide agents, including Agent Orange. The case is being remanded for an addendum opinion addressing the relationship between the Veteran's prostate cancer and active service.

The Veteran's bilateral hearing loss has been rated as noncompensable, and the claim for a compensable rating is denied.,From August 14, 2018, the Veteran meets the criteria for TDIU based on his service-connected disabilities.

The Veteran's disability rating for prostate cancer was restored from 60% to 60%, effective June 1, 2018.

The Veteran was granted service connection for right lung cancer, prostate cancer, prostatitis, PUD, and stomach cancer as due to herbicide exposure.,Service connection for cause of death is also granted.

The Board has remanded the Veteran's claims for prostate cancer, hearing loss, tinnitus, and an acquired psychiatric disorder due to incomplete records. The RO is required to obtain all relevant treatment records from the VA Medical Center in Orlando, Florida, between November 2011 and October 2017, and attempt to obtain Dr. R.'s treatment notes for his psychiatric disorders.